Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 1,095.00p on 13-03-2026 at 19:20:07
Change 32.50p 2.92%
Buy 1,200.00p
Sell 1,090.00p
Last Trade: Buy 9.00 at 1,200.00p
Day's Volume: 16,799
Last Close: 1,145.00p
Open: 1,090.00p
ISIN: GB00BQVXM815
Day's Range 1,090.00p - 1,200.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £70.36m
VWAP: 1,127.21229p
Shares in Issue: 6.43m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 9 1,200.00p SI Trade
16:28:28 - 13-Mar-26
Sell* 3 1,090.00p SI Trade
16:28:28 - 13-Mar-26
Sell* 2 1,095.00p Automatic Execution
16:28:28 - 13-Mar-26
Buy* 100 1,161.50p Ordinary
16:24:19 - 13-Mar-26
Unknown* 1 1,090.00p OTC Trade
16:18:54 - 13-Mar-26
Sell* 1 1,110.00p Ordinary
16:10:22 - 13-Mar-26
Unknown* 0 1,090.00p SI Trade
16:04:39 - 13-Mar-26
Sell* 13 1,095.00p Automatic Execution
16:04:39 - 13-Mar-26
Buy* 82 1,195.00p Ordinary
15:48:05 - 13-Mar-26
Sell* 2 1,095.00p Automatic Execution
15:45:54 - 13-Mar-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Mar 2026 (Fri) 1,090.00 1,200.00 1,090.00 1,145.00 16,799
12th Mar 2026 (Thu) 1,125.00 1,125.00 1,125.00 1,112.50 8,498
11th Mar 2026 (Wed) 1,125.00 1,160.00 1,050.00 1,090.00 17,572
10th Mar 2026 (Tue) 1,060.00 1,195.00 1,060.00 1,125.00 20,424
9th Mar 2026 (Mon) 922.00 1,150.00 922.00 1,127.50 27,223
6th Mar 2026 (Fri) 922.00 1,050.00 922.00 1,050.00 8,164
5th Mar 2026 (Thu) 890.00 1,010.00 890.00 993.50 8,689
4th Mar 2026 (Wed) 988.00 988.00 988.00 939.00 2,027
3rd Mar 2026 (Tue) 988.00 1,095.00 882.00 970.00 61,847
2nd Mar 2026 (Mon) 1,040.00 1,095.00 962.00 1,015.00 15,325
27th Feb 2026 (Fri) 1,075.00 1,170.00 1,055.00 1,107.50 14,301
26th Feb 2026 (Thu) 1,000.00 1,220.00 1,000.00 1,102.50 28,177
25th Feb 2026 (Wed) 1,085.00 1,205.00 1,085.00 1,080.00 32,369
24th Feb 2026 (Tue) 1,120.00 1,200.00 1,100.00 1,140.00 36,053
23rd Feb 2026 (Mon) 980.00 1,090.00 980.00 1,046.00 32,533
20th Feb 2026 (Fri) 924.00 1,030.00 910.00 999.00 28,478
19th Feb 2026 (Thu) 1,015.00 1,015.00 926.00 961.00 11,997
18th Feb 2026 (Wed) 896.00 1,020.00 850.00 964.00 49,982
17th Feb 2026 (Tue) 926.00 926.00 862.00 892.00 13,213
16th Feb 2026 (Mon) 956.00 960.00 930.00 926.00 14,506
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
27th Feb 2026 8:10 am RNS Total Voting Rights
24th Feb 2026 7:00 am RNS Holding(s) in Company
23rd Feb 2026 7:00 am RNS Exercise of Warrants and Issue of Equity
10th Feb 2026 3:52 pm RNS Issue of Equity - Correction
10th Feb 2026 7:00 am RNS Issue of Equity
30th Jan 2026 7:00 am RNS Total Voting Rights
12th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
8th Dec 2025 12:48 pm RNS Holding(s) in Company
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows

10th Feb 2026 19:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise

10th Feb 2026 12:12

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company news while mid-cap stocks held up better. Read More

SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials

10th Feb 2026 10:46

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,261.15
Change-44.00

Login to your account

Forgot Password?

Not Registered